Jeavons C M, Zeiner A R
Alcohol Clin Exp Res. 1984 Jul-Aug;8(4):352-8. doi: 10.1111/j.1530-0277.1984.tb05679.x.
Two groups (n = 20 each for pill and no pill groups) of young female social drinkers were tested with an acute ethanol dose (0.52 g/kg) as a 20% solution in water. Ethanol pharmacokinetics and acetaldehyde were repeatedly assayed from breath by a gas chromatograph. Cardiovascular indices were concurrently recorded. Groups did not differ on ethanol pharmacokinetics. However, the group on birth control pills reached a significantly higher acetaldehyde concentration than did the group of normally cycling females not on birth control pills (3.26 ng/ml vs. 1.45 ng/ml). Further, the pill (P) group showed significantly greater vasodilation 20 min postdrink as indexed by ear lobe plethysmography than did the no pill (NP) group (P = 160.3% vs. NP = 113.9%). Results are consistent with the interpretation that female sex steroids modulate aldehyde dehydrogenase function. Practical implications are that females with elevated steroids (either pregnant or on birth control pills) may be at greater risk for toxic effects of ethanol consumption.
两组年轻女性社交饮酒者(每组各20人,分别为服用避孕药组和未服用避孕药组)接受了急性乙醇剂量(0.52克/千克)测试,乙醇以20%的水溶液形式给药。通过气相色谱仪反复检测呼出气中的乙醇药代动力学和乙醛含量。同时记录心血管指标。两组在乙醇药代动力学方面无差异。然而,服用避孕药组的乙醛浓度显著高于未服用避孕药的正常月经周期女性组(3.26纳克/毫升对1.45纳克/毫升)。此外,饮酒20分钟后,通过耳垂体积描记法测得,服用避孕药(P)组的血管舒张程度显著大于未服用避孕药(NP)组(P组为160.3%,NP组为113.9%)。结果与女性性激素调节乙醛脱氢酶功能的解释一致。实际意义在于,性激素水平升高的女性(无论是孕妇还是服用避孕药者)可能因饮酒而面临更大的中毒风险。